跳至主要内容
临床试验/NCT04980599
NCT04980599已完成不适用

Effect of a Probiotic Strain Lactobacillus Paracasei K56 on Metabolic Symptom - a Pilot Study

Fudan University1 个研究点 分布在 1 个国家目标入组 118 人开始时间: 2021年1月10日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
118
试验地点
1
主要终点
visceral fat area

研究概览

简要总结

Recent data suggest that gut microbiota can function as an environmental factor that modulates the amount of body fat and obese individuals have an altered gut microbiota.The results of previous animal studies have suggest that a probiotic strain Lactobacillus paracasei K56 have reduced high-fat diet induced obesity.

In this before-after pilot study, the participants were randomly assigned to 8 groups to compare the fat-reducing effect of the Lactobacillus paracasei K56 by continuously supplementing different product prototypes , and screen the best probiotic K56 prototype with the effect of fat reduction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •BMI>=30kg/m2,or percent of body fat(PBF) >=25% for male, >=30 for female.
  • •Age: 18 - 60 years old adults

排除标准

  • •patients with severe chronic diseases (coronary heart disease, diabetes, hypertension, immune deficiency, mental disorders, tumors, liver and kidney dysfunction, etc.) and complications;irritable bowel syndrome
  • •History of intervention with fat-reducing drugs or health products in the past 2 months
  • •take weight control measures (diet, exercise, etc.) within the past month
  • •Those who cannot guarantee to maintain their current lifestyle during the trial period
  • •Those who fail to consume the tested samples as required, or fail to follow up on time, resulting in failure to determine the efficacy

研究组 & 干预措施

K56 very high dose -E1

Active Comparator

Probiotic drink (lactobacillus paracasei K56 10^11CFU) 350ml/d , for 60days

干预措施: probiotic drink with Lactobacillus paracasei K56 (Dietary Supplement)

K56 high dose-E3

Active Comparator

Probiotic powder 1.5g/sachet , 3.0g/d (lactobacillus paracasei K56 10^10cfu) , for 60days

干预措施: Probiotic powder E3 (Dietary Supplement)

K56 middle dose-E5

Active Comparator

Probiotic powder 8.0g/sachet , 8g/d ( Lactobacillus paracasei K56 10^9cfu) , for 60days

干预措施: Probiotic powder E5 (Dietary Supplement)

K56 low dose -E7

Active Comparator

probiotic k56 capsule, 2capsules/d ( Lactobacillus paracasei K56 10^7cfu) , for 60days

干预措施: probiotic capsule E7 (Dietary Supplement)

K56 middle dose-E9

Active Comparator

probiotic K56 capsule, 2capsules/d (Lactobacillus paracasei K56 10^9cfu) ,for 60days

干预措施: probiotic capsule E9 (Dietary Supplement)

K56 high dose-E1K

Active Comparator

probiotic K56 capsule, 2capsules/d (Lactobacillus paracasei K56 10^10cfu), for 60days

干预措施: probiotic capsule E10 (Dietary Supplement)

K56 very high dose-E11

Active Comparator

probiotic K56 capsule, 4capsules/d (Lactobacillus paracasei K56 10^11cfu) ,for 60days

干预措施: probiotic capsule E11 (Dietary Supplement)

control -E2

Placebo Comparator

maltodextrin , for 60days

干预措施: maltodextrin (Dietary Supplement)

结局指标

主要结局

visceral fat area

时间窗: 60days

visceral fat area (cm\^2) will be assessed at baseline and after 60days of intervention

percent body fat

时间窗: 60days

percent body fat (%) will be assessed at baseline and after 60days of intervention

次要结局

  • Serum Lipid Profile(60 days)
  • fasting blood glucose(60 days)
  • Glycated hemoglobin(60 days)
  • Glycosylated albumin(60 days)
  • skeletal muscle mass(60 days)
  • waist to hip ratio (WHR)(60 days)
  • Body Mass Index BMI(60 days)
  • body weight(60 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Zhijun Bao

Director

Fudan University

研究点 (1)

Loading locations...

相似试验